Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Other Non-Current Assets (2010 - 2026)

Geron's (GERN) quarterly Other Non-Current Assets came in at $5.7 million in Q2 2026, up 80.94% year-over-year from $3.1 million in Q2 2025, and down 4.17% quarter-over-quarter from $5.9 million in Q1 2026.

Analysis

Geron (GERN) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Geron has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $5.7 million for Q2 2026.

  • In Q2 2026, Other Non-Current Assets rose 80.94% year-over-year to $5.7 million; the TTM figure through Jun 2026 stood at $5.7 million (up 80.94% YoY), while the FY2025 annual figure was $5.9 million, up 45.75% from the prior year.
  • Other Non-Current Assets came in at $5.7 million for Q2 2026 at Geron, down from $5.9 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q1 2022 to a low of $2.7 million in Q3 2025.
  • Average Other Non-Current Assets over 5 years is $4.9 million, with a median of $4.8 million recorded in 2023.
  • Year-over-year, Other Non-Current Assets sank 45.95% in 2025 and soared 80.94% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $5.4 million in 2022, then slipped by 12.84% to $4.7 million in 2023, then fell by 13.16% to $4.1 million in 2024, then surged by 45.75% to $5.9 million in 2025, then dropped by 4.19% to $5.7 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.7 million in Q2 2026, $5.9 million in Q1 2026, and $5.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Geron 914.60 Mn 613.75 Mn - 5.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.70 Mn
Mar 31, 2026 5.94 Mn
Dec 31, 2025 5.95 Mn
Sep 30, 2025 2.67 Mn
Jun 30, 2025 3.15 Mn
Mar 31, 2025 4.04 Mn
Dec 31, 2024 4.08 Mn
Sep 30, 2024 4.93 Mn
Jun 30, 2024 4.74 Mn
Mar 31, 2024 4.71 Mn
Dec 31, 2023 4.70 Mn
Sep 30, 2023 5.20 Mn
Jun 30, 2023 4.75 Mn
Mar 31, 2023 4.69 Mn
Dec 31, 2022 5.39 Mn
Sep 30, 2022 5.51 Mn
Jun 30, 2022 5.70 Mn
Mar 31, 2022 6.32 Mn
Dec 31, 2021 4.80 Mn
Sep 30, 2021 4.88 Mn